Efficacy of an Assisted Therapy Optimizing Module to Improve Physician Adherence
A Prospective Open Randomised Trial to Test the Efficacy of an Assisted Therapy
Medical University Innsbruck
234 participants
Dec 3, 2024
INTERVENTIONAL
Conditions
Summary
Heart failure patients within the HM programme
Eligibility
Inclusion Criteria5
- AMPEL, CIP, Version: 1.2 Date: 27.03.2024
- Written, signed and dated informed consent for inclusion in the HM programme
- Male and female patients over 18 years of age.
- Hospitalised for decompensated heart failure requiring intravenous diuretics
- Need for iv diuresis in nonhospital setting because of impending hospitalization for cardiac decompensation
Exclusion Criteria3
- Multimorbidity (Charlson Comorbidity Index \> 6)
- Dementia
- Lack of willingness to participate
Interventions
We are planning to conduct a prospective, 1:1 randomized study within the HM program. Randomization occurs at the level of network physicians. Network physicians participating in the study are randomly assigned to either the AMPEL group (access to the module) or the non-AMPEL group (no access to the module) using a permuted block randomization scheme to ensure that there are the same number of patients in each study arm. Logical checks within the module ensure that once a network physician is assigned to an arm, he or she remains in that arm for the remainder of the stud
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06714344